Advertisement

Topics

Companies Related to "LPTX Announces Investigator Initiated Study Patients with DKK1" [Most Relevant Company Matches] RSS

10:08 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "LPTX Announces Investigator Initiated Study Patients with DKK1" found in our extensive corporate database of over 50,000 company records.

Showing "LPTX Announces Investigator Initiated Study Patients with DKK1" Companies 1–25 of 4,400+

Relevant

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...


Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee

HealthCare Pharmaceuticals, Inc.

HealthCare Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel, targeted therapies for the treatment of patients with cancer. DKN-01, our clinical-stage monoclonal antibody, is currently being tested in Phase 1b and Phase 2 clinical trials for patients with DKK1+ esophageal cancer and multiple mye...


Clinical Assistance Programs

Clinical Assistance Programs (CAP) is a clinical trial management organization. CAP provides site and data quality management, investigator training, and specialized compliance services to life science companies engaged in clinical trials.CAP was created to address many of the problems inherent in the clinical trial process such as site variability, data accuracy, investigator compliance, and the ...

MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in clinical study management systems designed for the global life sciences market. Applying critical insight, proven technology and unwavering support, MedNet delivers powerful, flexible and easy-to-use web-based solutions that support our customers' clinical studies, registries and investigator initiated trials. Since 2000, ...

Iconic Therapeutics

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and cancer. The company’s lead product candidate, ICON-1, is a novel fusion protein designed to address the basis of vision loss in AMD. By targeting inflammation and a...

EStudySite

eStudySite is dedicated to meeting deadlines and ensuring that patients stay the course. eStudySite has extensive clinical trial experience in Phase I, Phase II, and Phase III studies, conducting more than 56 successful studies since 1987. In addition, each of our coordinators is an RN with years of experience, who have constant access to the Principal Investigator and Sub-Investigator physicians,...

Dr.ROBERT SCALES

Robert Scales, Ph.D., is a native of Scotland, but he has resided in the Southwest for the past twenty years. He has his doctorate degree in education and he holds a faculty position in the School of Medicine at the University of New Mexico, where he conducts research and teaches motivational interviewing (MI). Currently, he is the Director of Cardiac Rehabilitation and Wellness at a hospital in...

nTouch Research Corporation

nTouch Research Corporation is a leading provider of Phase II-IV clinical trials services delivering investigator selection, patient recruitment and study management services for pharmaceutical, CRO, and biotechnology industries.nTouch owns and operates 16 highly-rated research centers across the USA serving 250 private practice investigators. Our strength is our commitment to sponsors, investigat...

Iconic Therapeutics, Inc.

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and cancer. The company’s lead product candidate, ICON-1, is a novel fusion protein designed to address the basis of vision loss in AMD. By targeting inflammation and a...

ACRO

Health outcomes aren't jeopardized when patients participate in randomized clinical trials of approved treatments, according to a new study. The results address misgivings some physicians have had about whether enrolling patients in a clinical trial might have a detrimental impact on their ability to receive individualized treatment. Conducted by a team led by Yale University's Dr. Cary P. Gross, ...

CFS Clinical and DrugDev

CFS Clinical (CFS) is a technology-enabled service provider focused on the business and financial management activities for clinical trials. Leveraging robust technology architecture and processes, CFS’ experts deliver best-in-class Investigator site payment and study startup solutions around the globe. The company’s solutions are utilized by spo...

CFS Clinical (CFS)

CFS Clinical is a specialty provider focused on the business and financial management activities of clinical trials. The company offers a unique blend of contract, regulatory and cutting-edge investigator grant payment management services. With focused expertise, innovative processes, and integrated technology CFS provides high quality, cost effective s...

Pharma Focus Israel

Pharma Focus Israel is a premium International Research Management Organization providing product development services in the life science and health care industries. Founded in 1992 by prominent experts in all realms of clinical services, the mission of PFC Pharma Focus is to bring a new look to the drug development experience by addressing the limitations of conventional study methods. With 15 ...

PLC Systems Inc.

PLC Medical Systems, Inc., the operating subsidiary of PLC Systems Inc., is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC's lead product, RenalGuard®, significantly reduces the onset of CIN in at-risk patients undergoing certain cardiac and vascular imaging procedures. CIN is a form of acute kidney...

Longboat Clinical

Longboat is a clinical trials software company dedicated to generating better study outcomes by creating a complete support structure for site staff, patients, monitors, and study teams - where protocol compliance becomes easy and instinctive. In the complex world of clinical development, Longboat’s cloud-based site and patient engagement platform emp...

GlobalCare Clinical Trials, Ltd

GlobalCare Clinical Trials, Ltd, is the leading global provider of ambulant healthcare services for clinical trials to government agencies and the world’s biopharmaceutical and medical device companies engaged in all phases of product development. GlobalCare provides innovative, GCP-compliant services by conducting selected study visits in the home or...

Corcept Therapeutics

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Our lead product, CORLUX, is currently in three Phase 3 clinical trials for the treatment of the psychotic features of psychotic major depression (PMD), a disorder that affects approximately three million adults in the United States ea...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

PharmaLinkFHI

Clinical Research Services: Project ManagementProtocol Development Investigator Recruitment Investigator and Staff Training Data Management (e-Process or paper based) Clinical Monitoring Biostatistics Clinical Report Writing Medical/Regulatory Support Quality of Life Studies Health Economics

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

Symphony Clinical Research

Symphony Clinical ResearchSM, is the global service leader in providing in-home and alternate-site clinical services to patients in all phases of clinical trials. Since 2003, the company has had a steadfast mission to combine its experience in clinical practices, project management, nursing and homecare to deliver a superior experience for sponsors, invest...

SAKK

SAKK conducts clinical trials for adult patients on a national level. The group also contributes to many international studies conducted by other research groups. The SAKK participates in all trials of the International Breast Cancer Study Group (IBCSG), a group with strong roots in Switzerland which has its Coordinating Center in Bern.The nucleus of the SAKK was initiated in 1965 by the cooperati...

VMR Institute

Welcome to VMR InstituteSince 1986 Jerry Sebag, MD has provided state-of-the-art care for disorders of the vitreous, macula, and retina. As a leading researcher, author, lecturer, and teacher, Dr. Sebag is able to offer patients pioneering treatments for blindness. As a co-investigator in various clinical research trials, Dr. Sebag offers patients new treatments and surgery not available at many o...


More From BioPortfolio on "LPTX Announces Investigator Initiated Study Patients with DKK1"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks